LAG3 transcriptomic expression correlates with high levels of PD-1, PD-L1, PD-L2, and CTLA-4 checkpoints and with high tumor mutational burden across cancers

被引:0
|
作者
Adashek, Jacob J.
Kato, Shumei
Pabla, Sarabjot
Nesline, Mary
Conroy, Jeffrey M.
Subbiah, Vivek
DePietro, Paul
Kurzrock, Razelle
机构
[1] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA USA
[3] Omni Seq Inc, Buffalo, NY USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX USA
[5] WIN Consortium, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2561
引用
收藏
页数:1
相关论文
共 50 条
  • [1] BTLA transcriptomic expression correlates with high levels of PD-1, PD-L2, and CTLA-4 checkpoints and with its ligand, HVEM, across diverse solid cancers
    Choi, Sharon
    Kurzrock, Razelle
    O'Keefe, Thomas
    Nishizaki, Daisuke
    Miyashita, Hirotaka
    Lee, Suzanna
    Nikanjam, Mina
    Eskander, Ramez Nassef
    Patel, Hitendra
    Botta, Gregory P.
    Pabla, Sarabjot
    Nesline, Mary K.
    Conroy, Jeffrey M.
    DePietro, Paul
    Sicklick, Jason K.
    Kato, Shumei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma
    Lee, Min Young
    Park, Chan-jeoung
    Cho, Young-Uk
    You, Eunkyoung
    Jang, Seongsoo
    Lee, Jung-Hee
    Hong, Jung Yong
    Yoon, Dok Hyun
    Suh, Cheolwon
    BLOOD, 2017, 130
  • [3] Immunomodulatory role for MicroRNAs: Regulation of PD-1/PD-L1 and CTLA-4 immune checkpoints expression
    Skafi, Najwa
    Fayyad-Kazan, Mohammad
    Badran, Bassam
    GENE, 2020, 754
  • [4] Expression and Prognostic Relevance of PD-1, PD-L1, and CTLA-4 Immune Checkpoints in Adrenocortical Carcinoma
    Landwehr, Laura-Sophie
    Altieri, Barbara
    Sbiera, Iuliu
    Remde, Hanna
    Kircher, Stefan
    Olabe, Julie
    Sbiera, Silviu
    Kroiss, Matthias
    Fassnacht, Martin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (09): : 2325 - 2334
  • [5] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Dimitrios Mathios
    Jacob Ruzevick
    Christopher M. Jackson
    Haiying Xu
    Sagar Shah
    Janis M. Taube
    Peter C. Burger
    Edward F. McCarthy
    Alfredo Quinones-Hinojosa
    Drew M. Pardoll
    Michael Lim
    Journal of Neuro-Oncology, 2015, 121 : 251 - 259
  • [6] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Mathios, Dimitrios
    Ruzevick, Jacob
    Jackson, Christopher M.
    Xu, Haiying
    Shah, Sagar
    Taube, Janis M.
    Burger, Peter C.
    McCarthy, Edward F.
    Quinones-Hinojosa, Alfredo
    Pardoll, Drew M.
    Lim, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (02) : 251 - 259
  • [7] Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Dimitrios Mathios
    Jacob Ruzevick
    Christopher M. Jackson
    Haiying Xu
    Sagar R. Shah
    Janis M. Taube
    Peter C. Burger
    Edward F. McCarthy
    Alfredo Quinones-Hinojosa
    Drew M. Pardoll
    Michael Lim
    Journal of Neuro-Oncology, 2016, 128 : 183 - 183
  • [8] PD-1, PD-L1 and PD-L2 expression in mouse prostate cancer
    Yang, Shijie
    Zhang, Qiuyang
    Liu, Sen
    Wang, Alun R.
    You, Zongbing
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2016, 4 (01): : 1 - 8
  • [9] Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
    H Yang
    C Bueso-Ramos
    C DiNardo
    M R Estecio
    M Davanlou
    Q-R Geng
    Z Fang
    M Nguyen
    S Pierce
    Y Wei
    S Parmar
    J Cortes
    H Kantarjian
    G Garcia-Manero
    Leukemia, 2014, 28 : 1280 - 1288
  • [10] Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
    Yang, H.
    Bueso-Ramos, C.
    DiNardo, C.
    Estecio, M. R.
    Davanlou, M.
    Geng, Q-R
    Fang, Z.
    Nguyen, M.
    Pierce, S.
    Wei, Y.
    Parmar, S.
    Cortes, J.
    Kantarjian, H.
    Garcia-Manero, G.
    LEUKEMIA, 2014, 28 (06) : 1280 - 1288